SUBSCRIBE
SUBSCRIBE
News   Deals

French ExonHit Therapeutics SA to Buy U.S. Diagnostics Firm

December 8, 2009 | 
1 min read

Bookmark and Share

Reuters -- French biotech ExonHit Therapeutics plans to use proceeds from a rights issue to buy a small diagnostics firm in the United States to expand use of its test for Alzheimer’s disease, the company said on Monday.

Mergers & acquisitions
MORE ON THIS TOPIC
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: Aerial view of the San Francisco skyline
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
January 15, 2025
 · 
4 min read
 · 
Tristan Manalac
The Gariep Dam overflowing. The dam is the largest in South Africa. It is in the Orange River on the border between the Free State and Eastern Cape Provinces. Monochrome
Deals
Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity
January 14, 2025
 · 
3 min read
 · 
Annalee Armstrong
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Gene therapy
Regenxbio Jumps on Potential $800M Rare Disease Deal With Nippon Shinyaku
January 14, 2025
 · 
2 min read
 · 
Tristan Manalac